Component

Human OCTN2-mediated cellular carnitine transport

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Fibroblasts carrying truncating OCTN2 variants from two unrelated patients lacked mediated carnitine transport.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Human primary-carnitine-deficiency patient fibroblasts and variant expression.
    limitations
    Genetic transport failure differs from low dietary intake.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    A broken cell-entry mechanism can produce primary carnitine deficiency.
    primary_references
    Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10051646/ · DOI 10.1073/pnas.96.5.2356
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 66–72

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human primary-carnitine-deficiency patient fibroblasts and variant expression. · source_derived_draft · unverified_draft

    ## l-carnitine-octn2-loss A broken cell-entry mechanism can produce primary carnitine deficiency. Fibroblasts carrying truncating OCTN2 variants from two unrelated patients lacked mediated carnitine transport. Model: Human primary-carnitine-deficiency patient fibroblasts and variant expression. Limitations: Genetic transport failure differs from low dietary intake. Evidence access: Primary abstract Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10051646/ · DOI 10.1073/pnas.96.5.2356
    Complete structured claim and evidence
  2. Transfecting patient fibroblasts with normal OCTN2 cDNA partially restored carnitine transport.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Patient fibroblast gene-complementation experiment.
    limitations
    This is experimental gene complementation, not a clinical gene-therapy result.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    Replacing the missing transport function rescued uptake in cells.
    primary_references
    Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10051646/ · DOI 10.1073/pnas.96.5.2356
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 74–80

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Patient fibroblast gene-complementation experiment. · source_derived_draft · unverified_draft

    ## l-carnitine-octn2-rescue Replacing the missing transport function rescued uptake in cells. Transfecting patient fibroblasts with normal OCTN2 cDNA partially restored carnitine transport. Model: Patient fibroblast gene-complementation experiment. Limitations: This is experimental gene complementation, not a clinical gene-therapy result. Evidence access: Primary abstract Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10051646/ · DOI 10.1073/pnas.96.5.2356
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards